Riskpilot← Back to searchSign inGet full accessPetBiomics Oy
OYActiveY-tunnus 1017592-0Mannerheimintie 164-aDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 19951 employees
Revenue 2024
EUR 30K
0% vs 2023
EBITDA margin
-174.2%
-2613150% vs 2023
Equity ratio
14.1%
Financial strength
Net profit 2024
EUR -204K
-5098675% vs 2023
| Revenue | EUR 30K | +0% |
| EBITDA | EUR -52K | -2613150% |
| Net profit | EUR -204K | -5098675% |
| Total assets | EUR 1,1M | +1% |
| Equity | EUR 152K | -20% |
| Employees | 1 | — |
Legal name
PetBiomics Oy
Y-tunnus number
1017592-0
Legal form
Osakeyhtiö
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
23. elokuuta 1995
Share capital
EUR 8 409
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on eläinlääkäripalvelut ja eläingenetiikan ja eläinmetabolomiikan palvelut sekä laboratorio- ja kliiniskemialliset analyysit kuten myös kaikki muu laillinen liiketoiminta sekä näihin liittyvät tehtävät.
Address
Mannerheimintie 164-a
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 30 | 30 | 30 |
| Staff expenses | −7 | −34 | −51 | −50 | −50 |
| EBITDA | −115 | −163 | −58 | 0 | −52 |
| Depreciation & amort. | −321 | −365 | −141 | −141 | −142 |
| EBIT | −436 | −528 | −198 | 0 | −194 |
| Net financials | −11 | −11 | −9 | −0 | −10 |
| Profit before tax | −446 | −538 | −207 | 0 | −204 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −446 | −538 | −207 | 0 | −204 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 048 | 1 169 | 958 | 1 065 | 1 076 |
| Equity | 7 | 291 | 84 | 190 | 152 |
| Long-term debt | 685 | 868 | 868 | 651 | 868 |
| Short-term debt | 357 | 10 | 6 | 223 | 56 |
| Total debt | 1 041 | 878 | 874 | 875 | 924 |
EBITDA margin
-174.2%
This company
15.8%
Market median
-1203% vs market
20202024
Equity ratio
14.1%
This company
38.2%
Market median
-63% vs market
20202024
Return on equity
-134.5%
This company
18.4%
Market median
-831% vs market
20202024
Net profit margin
-679.8%
This company
8.1%
Market median
-8493% vs market
20202024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20202024
Debt / equity
6.10×
This company
0.62×
Market median
-884% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Deputy Member | Deputy Member | 2021 |
| Former (3) | ||
TH Deputy Member | Deputy Member | 2019 – 2021 |
SS | Audit | 2012 – 2023 |
KA Deputy Member | Deputy Member | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2017 | |
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PetBiomics Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuomas Heikki Poskiparta | Deputy Member | 0 companies |
| Sami Seppo Sakari Posti | Audit | 0 companies |
| Panu Mikael Pohjola | Deputy Member | 0 companies |
| Katja Annika Jauni | Deputy Member | 0 companies |
| Hannes Tapani Lohi | Chairperson | 0 companies |
| Matti Aulis Koskelo | Board of Directors | 0 companies |